POMALIDOMIDE (POM) plus LOW-DOSE DEXAMETHASONE (LODEX) AFTER SECOND-LINE LENALIDOMIDE (LEN)-BASED TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PROGRESSION-FREE SURVIVAL ANALYSIS

被引：0

作者：

Siegel, D. S. ^{[1
]}

Schiller, G. J. ^{[2
]}

Song, K. ^{[3
]}

Agajanian, R. ^{[4
]}

Stockerl-Goldstein, K. ^{[5
]}

Kaya, H. ^{[6
]}

Sebag, M. ^{[7
]}

Reu, F. J. ^{[8
]}

Malek, E. ^{[9
]}

Talamo, G. ^{[10
]}

Mouro, J. ^{[11
]}

Chung, W. ^{[11
]}

Srinivasan, S. ^{[11
]}

Qian, M. ^{[11
]}

Rizvi, S. ^{[11
]}

Thakurta, A. ^{[11
]}

Bahlis, N. J. ^{[12
]}

机构：

[1] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Vancouver Gen Hosp, Vancouver, BC, Canada

[4] Oncol Inst Hope & Innovat, Downey, CA USA

[5] Washington Univ, Sch Med, St Louis, MO USA

[6] Canc Care Northwest, Spokane, WA USA

[7] McGill Univ, Ctr Hlth, Montreal, PQ, Canada

[8] Cleveland Clin, Cleveland, OH 44106 USA

[9] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA

[10] Penn State Hershey Canc Inst, Hershey, PA USA

[11] Celgene Corp, Summit, NJ USA

[12] Univ Calgary, Calgary, AB, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E1248

引用

页码：511 / 511

页数：1